Drug Name | IUPAC Name | Classification (KD Tripathi) | Drug Application | Receptors | Dosage Form | Route of Administration | Adverse Reactions | Appearance | Solubility | pKa Value | Functional Groups |
---|---|---|---|---|---|---|---|---|---|---|---|
Ethinyl Estradiol | 19-nor-17α-ethynyl-estr-4-en-3-one | Estrogen | Hormonal contraceptive, hormone replacement therapy | Estrogen receptors | Tablet (0.02 mg, 0.03 mg) Patch |
Oral, Transdermal | Nausea, headache, mood changes | White to off-white crystalline powder | Slightly soluble in water | pKa = 10.2 | Ethynyl, estrane |
Testosterone | 17β-Hydroxyandrost-4-en-3-one | Anabolic steroid | Hormone replacement therapy | Androgen receptors | Injection (100 mg/mL) Gel |
Intramuscular, Topical | Acne, mood swings, increased risk of cardiovascular events | White crystalline powder | Practically insoluble in water | pKa = 10.4 | Steroid, hydroxyl |
Progesterone | Pregn-4-ene-3,20-dione | Progestin | Hormonal contraceptive, hormone replacement therapy | Progesterone receptors | Tablet (10 mg, 100 mg) Injection (100 mg/mL) |
Oral, Intramuscular | Headache, breast tenderness, mood changes | White crystalline powder | Practically insoluble in water | pKa = 11.4 | Steroid, ketone |
Clomiphene | 2-[4-(2-Chloro-1,2-diphenyl)phenyl]-2-(4-pheynyl)phenyl]ethenol | Selective estrogen receptor modulator (SERM) | Infertility treatment | Estrogen receptors | Tablet (50 mg, 100 mg) | Oral | Hot flashes, nausea, headache | White to off-white crystalline powder | Slightly soluble in water | pKa = 9.5 | Chloro, phenyl |
Levonorgestrel | 13-ethyl-17-hydroxy-18-methyl-19-norpregna-4,9-diene-3,20-dione | Progestin | Hormonal contraceptive | Progesterone receptors | Tablet (0.75 mg, 1.5 mg) | Oral | Abdominal pain, headache, fatigue | White crystalline powder | Slightly soluble in water | pKa = 11.2 | Steroid, hydroxyl |
Oxytocin | (2S)-2-[[1-(4-Hydroxyphenyl)ethyl]amino]-4-methyl-1-[(2R)-1-phenylethyl]-2-oxobutanoic acid | Hormone | Labor induction, postpartum hemorrhage | Oxytocin receptors | Injection (10 units/mL) | Intravenous | Nausea, vomiting, uterine rupture | Clear colorless solution | Soluble in water | pKa not applicable | Peptide |
Danazol | 17α-ethynyl-1,2-testosterone | Androgen | Endometriosis, fibrocystic breast disease | Androgen receptors | Capsule (50 mg, 100 mg, 200 mg) | Oral | Weight gain, acne, hot flashes | White crystalline powder | Slightly soluble in water | pKa = 10.3 | Ethynyl, steroid |
Leuprolide | (5Z)-N-{(2S)-1-[(2S)-2-(amino-carbonyl)-4-methyl-5-oxopentanoic acid]-(1S)-2-(1H-imidazol-4-yl)acetyl}-N-ethyl-2-oxobutanamide | GnRH agonist | Prostate cancer, endometriosis | GnRH receptors | Injection (3.75 mg, 11.25 mg) | Intramuscular | Hot flashes, decreased libido | White to off-white powder | Soluble in water | pKa = 9.0 | Peptide |
Bromocriptine | Ergo-alkaloid derivative | Dopamine agonist | Hyperprolactinemia, acromegaly | Dopamine receptors | Tablet (2.5 mg) | Oral | Nausea, headache, dizziness | White crystalline powder | Slightly soluble in water | pKa = 7.8 | Alkaloid |
Raloxifene | 6-hydroxy-2-(4-hydroxyphenyl)-3-(1-pyrrolidinyl)-4H-chromen-4-one | SERM | Osteoporosis prevention, breast cancer prevention | Estrogen receptors | Tablet (60 mg) | Oral | Hot flashes, leg cramps | White crystalline powder | Slightly soluble in water | pKa = 10.2 | Phenol, ether |
Finasteride | (S)-N-(1,1-Dimethylethyl)-N-[(1S)-1-[(4-azabicyclo[2.2.1]heptan-3-yl)methyl]ethyl]prop-2-enamide | 5-alpha-reductase inhibitor | Benign prostatic hyperplasia, male pattern baldness | Androgen receptors | Tablet (1 mg, 5 mg) | Oral | Decreased libido, erectile dysfunction | White crystalline powder | Soluble in alcohol, insoluble in water | pKa = 4.1 | Amine, ketone |
Mycophenolate Mofetil | 2-(2-((4-(octyloxy)phenyl)(4-methylphenyl)methylthio)propyl)-1,3-dihydro-2H-isoindol-1-one | Immunosuppressant | Prevent organ rejection | Not specific | Capsule (250 mg) | Oral | Diarrhea, nausea, infection risk | White crystalline powder | Soluble in methanol, slightly soluble in water | pKa = 6.2 | Carboxylic acid, amine |
Cabergoline | 1-[(6-Ethyl-1,3-dihydro-2H-indol-2-yl)carbonyl]-2-(1-propylpyrrolidin-2-yl)ethylamine | Dopamine agonist | Hyperprolactinemia | Dopamine receptors | Tablet (0.5 mg) | Oral | Nausea, headache, dizziness | White to off-white powder | Slightly soluble in water | pKa = 8.3 | Alkaloid |
Testosterone Undecanoate | 17β-Undecanoate | Anabolic steroid | Hormone replacement therapy | Androgen receptors | Injection (250 mg/mL) | Intramuscular | Acne, mood swings | White crystalline powder | Practically insoluble in water | pKa = 10.4 | Steroid, ester |
Desogestrel | 13-ethyl-17-hydroxy-18-methyl-19-norpregna-4,9-diene-3,20-dione | Progestin | Hormonal contraceptive | Progesterone receptors | Tablet (0.15 mg) | Oral | Abdominal pain, headache | White crystalline powder | Slightly soluble in water | pKa = 11.2 | Steroid, hydroxyl |
Estradiol Valerate | 17β-Estradiol 17-valerate | Estrogen | Hormonal replacement therapy | Estrogen receptors | Injection (5 mg/mL) | Intramuscular | Nausea, breast tenderness | White crystalline powder | Slightly soluble in water | pKa = 10.0 | Steroid, ester |
Ulipristal Acetate | 17-[(1-oxo-2-propenyl)oxy]-11β-hydroxy-19-norpregna-4,9-diene-3,20-dione | Selective progesterone receptor modulator | Emergency contraception | Progesterone receptors | Tablet (30 mg) | Oral | Headache, nausea | White to off-white powder | Slightly soluble in water | pKa = 7.5 | Ketone, steroid |
Asoprisnil | (3S,4S)-3-[(2S)-2-(4-chlorophenyl)thiazolidin-4-yl]methyl-2,3-dihydro-1H-isoindole-1,3(2H)-dione | Selective progesterone receptor modulator | Uterine fibroids | Progesterone receptors | Tablet (5 mg) | Oral | Hot flashes, headache | White to off-white powder | Slightly soluble in water | pKa = 7.5 | Thiazole, amine |
Estetrol | (2S,3S)-2-(3-Hydroxy-2-methylphenyl)-3-(1-hydroxyethyl)-4-phenylbutanoic acid | Estrogen | Hormonal contraception | Estrogen receptors | Tablet (15 mg) | Oral | Nausea, headache | White crystalline powder | Slightly soluble in water | pKa = 10.1 | Steroid, hydroxyl |
Progestin | Varies by compound | Progestin | Hormonal contraceptive, hormone replacement therapy | Progesterone receptors | Capsule/Tablets | Oral | Weight gain, breast tenderness | Varies | Varies | Varies | Varies |
Mifepristone | (11β-(4-Dimethylamino-phenyl) 17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one | Antiprogestin | Medical abortion | Progesterone receptors | Tablet (200 mg) | Oral | Abdominal pain, nausea | White crystalline powder | Soluble in water | pKa = 6.7 | Ketone, steroid |